RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia
- DOI
- 10.1056/evidoa2200325
- Published
- 2023-11-28
- Container
- NEJM Evidence
- Publisher
- Massachusetts Medical Society
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1056/evidoa2200325,
title = {RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia},
author = {Daniel Gaudet and Peter Clifton and David Sullivan and John Baker and Christian Schwabe and Susan Thackwray and Russell Scott and James Hamilton and Bruce Given and Stacey Melquist and Rong Zhou and Ting Chang and Javier San Martin and Gerald F. Watts and Ira J. Goldberg and Joshua W. Knowles and Robert A. Hegele and Christie M. Ballantyne},
year = {2023},
journal = {NEJM Evidence},
doi = {10.1056/evidoa2200325},
url = {https://doi.org/10.1056/evidoa2200325}
}RIS
TY - JOUR TI - RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia AU - Daniel Gaudet AU - Peter Clifton AU - David Sullivan AU - John Baker AU - Christian Schwabe AU - Susan Thackwray AU - Russell Scott AU - James Hamilton AU - Bruce Given AU - Stacey Melquist AU - Rong Zhou AU - Ting Chang AU - Javier San Martin AU - Gerald F. Watts AU - Ira J. Goldberg AU - Joshua W. Knowles AU - Robert A. Hegele AU - Christie M. Ballantyne PY - 2023 JO - NEJM Evidence DO - 10.1056/evidoa2200325 UR - https://doi.org/10.1056/evidoa2200325 ER -
APA
Gaudet, D., Clifton, P., Sullivan, D., Baker, J., Schwabe, C., Thackwray, S., Scott, R., Hamilton, J., Given, B., Melquist, S., Zhou, R., Chang, T., Martin, J. S., Watts, G. F., Goldberg, I. J., Knowles, J. W., Hegele, R. A., & Ballantyne, C. M. (2023). RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia. NEJM Evidence. https://doi.org/10.1056/evidoa2200325
Source records
- crossref · retrieved 2026-11-10T07:29:15.749Z